Peer-reviewedCC BY-NC-ND 4.0Nature Communications
Target trial emulation of effectiveness of COVID-19 mRNA vaccination during pregnancy in four European countries
Related
- Optimising HPV Vaccination for Cervical Cancer Prevention in Women Living with HIV: A Cost-Effectiveness Analysis Across 13 African Countries
- Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation
- Hepatitis B vaccination coverage and factors associated with higher uptake among children aged 5–35 months in eight selected sub-Saharan African countries: a multilevel ordinal logistic regression analysis
- Assessing coping, loneliness, resilience and partner burden in patients with skin conditions: protocol for a multicentre cross-sectional study across 23 dermatology centres in 15 European countries
- SARS-CoV-2 mRNA Vaccination in Pregnancy and Child Neurodevelopment at 18 to 30 Months
BibTeX
@article{mercadebesora2026target,
title = {{Target trial emulation of effectiveness of COVID-19 mRNA vaccination during pregnancy in four European countries}},
author = {Núria Mercadé-Besora and Berta Raventós and Nhung TH Trinh and Huiqi Li and Saeed Hayati and Agustina Giuliodori and Theresa Burkard and Edward Burn and Martí Català and Daniel Prieto-Alhambra and Daniel R. Morales and Fredrik Nyberg and Hedvig Marie Egeland Nordeng and Talita Duarte-Salles},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-78469-x},
url = {https://www.nature.com/articles/s41467-026-78469-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Target trial emulation of effectiveness of COVID-19 mRNA vaccination during pregnancy in four European countries
AU - Núria Mercadé-Besora
AU - Berta Raventós
AU - Nhung TH Trinh
AU - Huiqi Li
AU - Saeed Hayati
AU - Agustina Giuliodori
AU - Theresa Burkard
AU - Edward Burn
AU - Martí Català
AU - Daniel Prieto-Alhambra
AU - Daniel R. Morales
AU - Fredrik Nyberg
AU - Hedvig Marie Egeland Nordeng
AU - Talita Duarte-Salles
PY - 2026
DA - 2026/10/16
JO - Nature Communications
DO - 10.1038/s41467-026-78469-x
UR - https://www.nature.com/articles/s41467-026-78469-x
SN - 2041-1723
ER -